{"id": "1369686766639267847", "creation": 1615393747.0, "user_id": "18026170", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": ".@CEPIvaccines awards $33M to @VBIVaccines to develop #eVLP #vaccine leads vs #COVID19 #variants\n\nInitial focus on moving VBI-2905 vs #SARSCoV2 B.1.351 #spike protein through Ph1 #ClinicalTrials\n\nhttps://t.co/0NV8FLI89h\n#InfectiousDiseases #VirusLikeParticles https://t.co/JWN9NmKHTA", "first_save": 1634559108.199414, "hashtags": ["#EVLP", "#VACCINE", "#COVID19", "#VARIANTS", "#SARSCOV2", "#SPIKE", "#CLINICALTRIALS", "#INFECTIOUSDISEASES", "#VIRUSLIKEPARTICLES"]}